Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -472 | -2,610 | N/A | -1,870 | -460 |
| Depreciation Amortization | 41 | 160 | N/A | 80 | 40 |
| Accounts receivable | -223 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -24 | N/A | N/A | N/A | N/A |
| Other Working Capital | -255 | -80 | N/A | 4 | -60 |
| Other Operating Activity | 79 | -100 | 0 | 536 | -10 |
| Operating Cash Flow | $-854 | $-2,630 | $N/A | $-1,250 | $-490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -9 | N/A | -8 | 0 |
| Other Investing Activity | -1 | -1 | 0 | -2 | 0 |
| Investing Cash Flow | $-5 | $-10 | $N/A | $-10 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 8,650 | 0 | 8,950 | -40 |
| Financing Cash Flow | $N/A | $8,650 | $N/A | $8,950 | $-40 |
| Exchange Rate Effect | -111 | 100 | N/A | -170 | -20 |
| Beginning Cash Position | 8,887 | 2,460 | N/A | 2,550 | 2,410 |
| End Cash Position | 7,917 | 8,570 | N/A | 10,070 | 1,850 |
| Net Cash Flow | $-970 | $6,110 | $N/A | $7,520 | $-550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -854 | -2,630 | N/A | -1,250 | -490 |
| Capital Expenditure | -4 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -858 | -2,630 | 0 | -1,250 | -490 |